SEC Filing Summary: Tempur-Pedic International Inc.
Business Context and Reporting Period
This Form 8-K was filed on November 22, 2004, by Tempur-Pedic International Inc. (not Somnigroup International Inc., as noted in the metadata request). The report discloses a material definitive agreement entered into on November 17, 2004.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures. The document focuses exclusively on the terms of a secondary stock offering by selling stockholders.
Material Changes and Transactions
- Underwriting Agreement: Tempur-Pedic International Inc. entered into an agreement with Lehman Brothers Inc., Goldman, Sachs & Co., UBS Securities LLC, Piper Jaffray & Co., and Adams Harkness, Inc.
- Share Sale: Selling Stockholders agreed to sell 13,000,000 shares of the company's common stock to the underwriters.
- Over-Allotment Option: The underwriters were granted an option to purchase up to an additional 1,950,000 shares to cover over-allotments.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or specific risk factors beyond the standard disclosure of the underwriting agreement. No pro forma financial information or financial statements of acquired businesses were included.
Investor Verification Checklist
- Verify the identity of the "Selling Stockholders" to determine if this is a primary offering by the company or a secondary sale by existing shareholders.
- Confirm the offering price per share, which is not stated in this summary text but would be in the attached Underwriting Agreement (Exhibit 1.1).
- Review the total proceeds expected from the sale of 13,000,000 shares plus any over-allotment shares.
- Check subsequent filings to see if the over-allotment option was exercised.